Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy

Xinyu Song1 Department of Medical Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected]; [email protected];2 School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong, China

Dawei Chen3 Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Jinan, Shandong, China

Ma Yuan4 Department of Medical Oncology, Weihai Central Hospital, Weihai, Shandong, China

Haiyong Wang1 Department of Medical Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Zhehai Wang1 Department of Medical Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong, China, [email protected]; [email protected]Correspondence[email protected] [email protected]

Pages 6677-6683 | Published online: 05 Dec 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

SiegelRLMillerKDJemalACancer Statistics, 2017CA Cancer J Clin201767173028055103
PubMed Web of Science ®Google Scholar
LiNXuMCaiMYElevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancerCancer Epidemiol201539576376826159684
PubMed Web of Science ®Google Scholar
de MartelCFranceschiSInfections and cancer: established associations and new hypothesesCrit Rev Oncol Hematol200970318319418805702
PubMed Web of Science ®Google Scholar
TakahashiHOgataHNishigakiRBroideDHKarinMTobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammationCancer Cell2010171899720129250
PubMed Web of Science ®Google Scholar
ParkEJLeeJHYuGYDietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expressionCell2010140219720820141834
PubMed Web of Science ®Google Scholar
HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
PubMed Web of Science ®Google Scholar
HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
PubMed Web of Science ®Google Scholar
GuthrieGJCharlesKARoxburghCSHorganPGMcmillanDCClarkeSJThe systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancerCrit Rev Oncol Hematol201388121823023602134
PubMed Web of Science ®Google Scholar
MiyamotoRInagawaSSanoNTadanoSAdachiSYamamotoMThe neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patientsEur J Surg Oncol201844560761229478743
PubMed Web of Science ®Google Scholar
KadamPDChuanHHErratum to: Rectocutaneous fistula with transmigration of the suture: a rare delayed complication of vault fixation with the sacrospinous ligamentInt Urogynecol J201627350526811110
PubMed Web of Science ®Google Scholar
ZhangJZhangHYLiJShaoXYZhangCXThe elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysisOncotarget2017840688376884628978160
PubMedGoogle Scholar
ChuaWCharlesKABaracosVEClarkeSJNeutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancerBr J Cancer201110481288129521448173
PubMed Web of Science ®Google Scholar
BealEWWeiLEthunCGElevated NLR in gallbladder cancer and cholangiocarcinoma–making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy ConsortiumHPB2016181195095727683047
PubMed Web of Science ®Google Scholar
IimoriNKashiwagiSAsanoYClinical significance of the neutrophil-to-lymphocyte ratio in endocrine therapy for stage IV breast cancerIn Vivo201832366967529695577
PubMed Web of Science ®Google Scholar
TazzymanSBarrySTAshtonSInhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growthInt J Cancer2011129484785821328342
PubMed Web of Science ®Google Scholar
von BernstorffWVossMFreichelSSystemic and local immunosuppression in pancreatic cancer patientsClin Cancer Res200173 Suppl925s932s11300493
PubMed Web of Science ®Google Scholar
HasencleverDDiehlVA prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s DiseaseN Engl J Med199833921150615149819449
PubMed Web of Science ®Google Scholar
Ray-CoquardICropetCvan GlabbekeMLymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomasCancer Res200969135383539119549917
PubMed Web of Science ®Google Scholar
MotomuraTShirabeKManoYNeutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironmentJ Hepatol2013581586422925812
PubMed Web of Science ®Google Scholar
TeramukaiSKitanoTKishidaYPretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03Eur J Cancer200945111950195819231158
PubMed Web of Science ®Google Scholar
IetomiKA study on the role of granulocytes in carcinoma-bearing hosts--G/L ratio as a new host indicatorNihon Gan Chiryo Gakkai Shi19902536626712351858
PubMedGoogle Scholar
LinGNPengJWLiuPPLiuDYXiaoJJChenXQElevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatmentAsia Pac J Clin Oncol2017135e189e19425359280
PubMed Web of Science ®Google Scholar
BerardiRRinaldiSSantoniMPrognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapyOncotarget2001718269162624
Google Scholar
MajetiBKLeeJHSimmonsBHShojaeiFVEGF is an important mediator of tumor angiogenesis in malignant lesions in a genetically engineered mouse model of lung adenocarcinomaBMC Cancer20131321321623627488
PubMed Web of Science ®Google Scholar
QiangGLiangCXiaoFPrognostic significance of platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysisOnco Targets Ther2016986987626955285
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date